Literature DB >> 3754757

Atracurium infusion in the intensive care unit.

A J Wadon, S Dogra, S Anand.   

Abstract

An open study of 38 infusions of atracurium in 33 patients requiring neuromuscular blockade for ventilation was carried out. Consecutive patients requiring ventilation were studied and there were no exclusions. The initial rate of infusion was 0.4 mg kg-1 h-1 and this was adjusted according to clinical observation and the results of neuromuscular stimulation. The average infusion rate in the series was 0.59 mg kg-1 h-1. Patients were sedated using a morphine infusion at a rate of 2-4 mg kg-1 h-1. Satisfactory blockade was achieved in all cases. Time for spontaneous recovery following termination of infusion was recorded, the average recovery time being 39.2 min. Emphasis was placed on recording any possible serious toxic effects attributable to long-term atracurium infusions, possible toxic effects were considered and a satisfactory explanation of such effects was found in all cases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754757     DOI: 10.1093/bja/58.suppl_1.64s

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  Clinical manifestations and neurodevelopmental outcome following an event of accidental intramuscular injection of atracurium in newborns.

Authors:  Wu-Shiun Hsieh; Hsiu-Min Huang; Steven Peng; Jao-Shwann Liang; Cheung Leung; Geng-Chang Yeh; Chao-Ching Huang; Suh-Fang Jeng
Journal:  Eur J Pediatr       Date:  2006-01-21       Impact factor: 3.183

Review 2.  Atracurium and laudanosine pharmacokinetics in acute renal failure.

Authors:  J M Hunter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

3.  Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.

Authors:  Annelijn M Meeder; Marijke S van der Steen; Annemieke Rozendaal; Arthur R H van Zanten
Journal:  BMJ Case Rep       Date:  2016-10-03

4.  The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.

Authors:  A J Pearson; N J Harper; B J Pollard
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

5.  Comparison of atracurium and pancuronium in mechanically ventilated neonates.

Authors:  A Piotrowski
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 6.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

Review 7.  The use of muscle relaxants in the intensive care unit.

Authors:  M D Sharpe
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.